We’re cutting our price target on Danaher as frustration mounts after a messy quarter
Danaher shares are under pressure Wednesday as the Club holding’s fourth-quarter earnings results came in mixed and guidance disappointed. The…
Health
Read More
RFK Jr. Senate confirmation hearing highlights
Robert F. Kennedy Jr., President Donald Trump‘s controversial pick to lead the Department of Health and Human Services, testified Wednesday…
23andMe is exploring strategic alternatives, looking to raise capital
Anne Wojcicki, co-founder and chief executive officer of 23andme Inc., during the South by Southwest (SXSW) festival in Austin, Texas,…
Trump signs sweeping order to further restrict trans care for minors nationwide
President Donald Trump signed a broad executive order targeting transition-related medical care for minors Tuesday. The order, titled “Protecting Children…
Trump made sweeping health care changes in first week
U.S. President Donald Trump attends a House Republican members conference meeting in Trump National Doral resort, in Miami, Florida, U.S….
Novo Nordisk’s Ozempic wins FDA approval for chronic kidney disease
The Food and Drug Administration on Tuesday approved Novo Nordisk‘s Ozempic for patients with chronic kidney disease and diabetes, expanding…
Food as medicine startups could benefit
Robert Kennedy Jr., U.S. President-elect Donald Trump’s nominee to run the Department of Health and Human Services, arrives at the…
We're lightening up on a rallying stock that's grown too big in our portfolio
The sale also comes as our trusted momentum indicator moved further into overbought territory. Source link
We’re trimming a 2025 top gainer, taking profits on market move into health stocks
We are selling 75 shares of GE Healthcare at roughly $90 each. Following Monday’s trade, Jim Cramer’s Charitable Trust will…
Trump health care plan likely good for pharmaceutical companies
U.S. President Donald Trump speaks about prescription drug prices during an appearance in the Brady Press Briefing Room at the…